Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 441

1.

Identification of loci of functional relevance to Barrett's esophagus and esophageal adenocarcinoma: Cross-referencing of expression quantitative trait loci data from disease-relevant tissues with genetic association data.

Schröder J, Schüller V, May A, Gerges C, Anders M, Becker J, Hess T, Kreuser N, Thieme R, Ludwig KU, Noder T, Venerito M, Veits L, Schmidt T, Fuchs C, Izbicki JR, Hölscher AH, Dakkak D, Jansen-Winkeln B, Moulla Y, Lyros O, Niebisch S, Mehdorn M, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Mangold E, Nöthen MM, Moebus S, Knapp M, Neuhaus H, Rösch T, Ell C, Gockel I, Schumacher J, Böhmer AC.

PLoS One. 2019 Dec 31;14(12):e0227072. doi: 10.1371/journal.pone.0227072. eCollection 2019.

2.

Infiltration Depth is the Most Relevant Risk Factor for Overall Metastases in Early Esophageal Adenocarcinoma.

Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Braun S, Ell C, Lorenz D.

World J Surg. 2019 Dec 18. doi: 10.1007/s00268-019-05291-6. [Epub ahead of print]

PMID:
31853591
3.

Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies.

Böhmer AC, Hecker J, Schröder J, Gharahkhani P, May A, Gerges C, Anders M, Becker J, Hess T, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Fuchs C, Izbicki JR, Hölscher AH, Dietrich A, Moulla Y, Lyros O, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Moebus S, Knapp M, Neuhaus H, Rösch T, Ell C, Nöthen MM, Whiteman DC, Tomlinson I, Jankowski J, Fitzgerald RC, Palles C, Vaughan TL, Gockel I, Thrift AP, Fier H, Schumacher J.

Cancer Epidemiol Biomarkers Prev. 2019 Nov 20. doi: 10.1158/1055-9965.EPI-19-0374. [Epub ahead of print]

PMID:
31748258
4.

S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.

Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:.

Z Gastroenterol. 2019 Mar;57(3):e120. doi: 10.1055/a-0884-5474. Epub 2019 Apr 5. German. No abstract available.

PMID:
30952167
5.

S3-Leitlinie – Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus.

Porschen R, Fischbach W, Gockel I, Hollerbach S, Hölscher A, Jansen PL, Miehlke S, Pech O, Stahl M, Thuss-Patience P, Vanhoefer U; und die Mitarbeiter der Leitlinienkommission; Collaborators:.

Z Gastroenterol. 2019 Mar;57(3):336-418. doi: 10.1055/a-0833-5712. Epub 2019 Mar 12. German. No abstract available. Erratum in: Z Gastroenterol. 2019 Mar;57(3):e120.

PMID:
30861559
Free Article
6.

No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study.

Dong J, Gharahkhani P, Chow WH, Gammon MD, Liu G, Caldas C, Wu AH, Ye W, Onstad L, Anderson LA, Bernstein L, Pharoah PD, Risch HA, Corley DA, Fitzgerald RC; Stomach and Esophageal Cancer Study Consortium, Iyer PG, Reid BJ, Lagergren J, Shaheen NJ, Vaughan TL, MacGregor S, Love S, Palles C, Tomlinson I, Gockel I, May A, Gerges C, Anders M, Böhmer AC, Becker J, Kreuser N, Thieme R, Noder T, Venerito M, Veits L, Schmidt T, Schmidt C, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Mayershofer R, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, Jankowski J, Schumacher J, Neale RE, Whiteman DC, Thrift AP.

Clin Gastroenterol Hepatol. 2019 Oct;17(11):2227-2235.e1. doi: 10.1016/j.cgh.2019.01.041. Epub 2019 Feb 1.

PMID:
30716477
7.

The overall metastatic rate in early esophageal adenocarcinoma: long-time follow-up of surgically treated patients.

Oetzmann von Sochaczewski C, Haist T, Pauthner M, Mann M, Fisseler-Eckhoff A, Braun S, Ell C, Lorenz D.

Dis Esophagus. 2019 Nov 13;32(9). pii: doy127. doi: 10.1093/dote/doy127.

PMID:
30596900
8.

Non-thermal ablation of non-neoplastic Barrett's esophagus with the novel EndoRotor® resection device.

Knabe M, Blößer S, Wetzka J, Ell C, May A.

United European Gastroenterol J. 2018 Jun;6(5):678-683. doi: 10.1177/2050640618758214. Epub 2018 Feb 5.

9.

Sedation in GI endoscopy: a paradigm shift has taken place.

Behrens A, Ell C.

Gut. 2018 Apr 20. pii: gutjnl-2018-316556. doi: 10.1136/gutjnl-2018-316556. [Epub ahead of print] No abstract available.

PMID:
29678932
10.

Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications.

Behrens A, Kreuzmayr A, Manner H, Koop H, Lorenz A, Schaefer C, Plauth M, Jetschmann JU, von Tirpitz C, Ewald M, Sackmann M, Renner W, Krüger M, Schwab D, Hoffmann W, Engelke O, Pech O, Kullmann F, Pampuch S, Lenfers B, Weickert U, Schilling D, Boehm S, Beckebaum S, Cicinnati V, Erckenbrecht JF, Dumoulin FL, Benz C, Rabenstein T, Haltern G, Balsliemke M, de Mas C, Kleber G, Pehl C, Vogt C, Kiesslich R, Fischbach W, Koop I, Kuehne J, Breidert M, Sass NL, May A, Friedrich C, Veitt R, Porschen R, Ellrichmann M, Arlt A, Schmitt W, Dollhopf M, Schmidbaur W, Dignass A, Schmitz V, Labenz J, Kaiser G, Krannich A, Barteska N, Ell C.

Gut. 2018 Jan 3. pii: gutjnl-2015-311037. doi: 10.1136/gutjnl-2015-311037. [Epub ahead of print]

PMID:
29298872
11.

[Endoscopic Therapy of Gastrointestinal Neoplasia].

Bruun S, Knabe M, Ell C.

Dtsch Med Wochenschr. 2017 Aug;142(15):1139-1143. doi: 10.1055/s-0043-110493. Epub 2017 Aug 1. German.

PMID:
28763824
12.

Editorial: the diminishing returns of normalisation of the oesophageal mucosa-Authors' reply.

Mastracci L, Fiocca R, Engstrom C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L.

Aliment Pharmacol Ther. 2017 Jul;46(1):73-74. doi: 10.1111/apt.14118. No abstract available.

13.

The dynamics of the oesophageal squamous epithelium 'normalisation' process in patients with gastro-oesophageal reflux disease treated with long-term acid suppression or anti-reflux surgery.

Mastracci L, Fiocca R, Engström C, Attwood S, Ell C, Galmiche JP, Hatlebakk JG, Långström G, Eklund S, Lind T, Lundell L.

Aliment Pharmacol Ther. 2017 May;45(10):1339-1349. doi: 10.1111/apt.14038. Epub 2017 Mar 21.

14.

Endoscopic resection for patients with mucosal adenocarcinoma of the esophagus.

Knabe M, May A, Ell C.

Minerva Gastroenterol Dietol. 2016 Dec;62(4):281-295. Epub 2016 Sep 21. Review.

PMID:
27652683
15.

Portal vein leiomyosarcoma: a case report and review of the literature.

Gohrbandt AE, Hansen T, Ell C, Heinrich SS, Lang H.

BMC Surg. 2016 Sep 1;16(1):60. doi: 10.1186/s12893-016-0174-x. Review.

16.

[Safety of sedation during gastroscopy and colonoscopy in low-risk patients - results of a retrospective subgroup analysis of a registry study including over 170 000 endoscopies].

Behrens A, Ell C; Studiengruppe ALGK-ProSed.

Z Gastroenterol. 2016 Aug;54(8):733-9. doi: 10.1055/s-0042-108655. Epub 2016 Aug 16. German.

PMID:
27529524
17.

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis.

Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM; Barrett's and Esophageal Adenocarcinoma Consortium (BEACON); Esophageal Adenocarcinoma GenEtics Consortium (EAGLE); Wellcome Trust Case Control Consortium 2 (WTCCC2), Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J.

Lancet Oncol. 2016 Oct;17(10):1363-1373. doi: 10.1016/S1470-2045(16)30240-6. Epub 2016 Aug 12.

18.

ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).

Hoeppner J, Lordick F, Brunner T, Glatz T, Bronsert P, Röthling N, Schmoor C, Lorenz D, Ell C, Hopt UT, Siewert JR.

BMC Cancer. 2016 Jul 19;16:503. doi: 10.1186/s12885-016-2564-y.

19.

Perioperative and Palliative Chemotherapy for Esophageal Cancer.

Behrens A, Ell C, Lordick F.

Viszeralmedizin. 2015 Oct;31(5):341-6. doi: 10.1159/000438470. Epub 2015 Oct 6. Review.

20.

Endoscopic Therapy of Early Carcinoma of the Oesophagus.

Knabe M, May A, Ell C.

Viszeralmedizin. 2015 Oct;31(5):320-5. doi: 10.1159/000441075. Epub 2015 Oct 19. Review.

Supplemental Content

Loading ...
Support Center